Two young Alabama women formed a bond over a rare germ cell cancer affecting only 1,000 women across the United States.

A special presentation of the popular play at Virginia Samford Theatre will benefit ovarian cancer research at UAB.

UAB offers two national clinical trials with customized treatment for lung cancer patients.

Three-year, $2 million PCORI grant will give UAB caregivers an opportunity to develop surgical protocols that enhance coordination of care and improve quality of life for women with endometrial cancer.

The Women and Infants Center and its physicians, nurses and staff have passed numerous milestones and garnered honors with patient care as the key focus.

Renowned UAB HPV expert Warner Huh says new nine-valent HPV vaccine has the potential to eradicate the majority of cervical cancer.

HPV testing alone is an effective alternative to current cervical cancer screening methods that use a Pap smear, or Pap smear-plus HPV test.

Partridge was honored for his exceptional talents and his commitment to make progress towards finishing the fight against cancer.

Alvarez's work in ovarian cancer research honored.

UAB faculty will give 25 presentations at ASCO scientific meeting; topics also include ovarian and breast cancers and AML, or acute myeloid leukemia.

Cancer researcher honored for outstanding care to cancer patients.

Professor and director, UAB Division of Gynecological Oncology

Areas of expertise: gynecological cancers, cancer prevention

UAB researcher presented several gynecological oncology studies to a national gathering of doctors.

UAB researcher explores use of antibody mechanism in platelet production that may reduce ovarian cancer progression.

Professor and Director of the Division of Gynecologic Oncology,
Margaret Cameron Spain Endowed Chair in Obstetrics/Gynecology,
Scientist in the UAB Comprehensive Cancer Center

Areas of expertise: Gynecologic oncology, cancer vaccine, robotic surgery for gyn/onc, ovarian cancer, endometrial cancer

A researcher in the UAB Comprehensive Cancer Center has been selected for the inaugural Ovarian Cancer Academy Award, part of the U.S. Department of Defense funding for cancer research. Assistant Professor Charles Landen, M.D., of the Division of Gynecologic Oncology, is one of seven early career investigators chosen for the grant. The award is $1.06 million from the Office of Congressionally Directed Medical Research.

Landen works to identify and characterize a subpopulation of ovarian cancer cells that have enhanced ability to survive chemotherapy and cause recurrence. Understanding this class of cells may lead to discoveries of key pathways than can be targeted with novel anti-cancer therapies.